Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens


      OBJECTIVE: Our purpose was to investigate whether conization for cervical intraepithelial neoplasia eliminates human papillomavirus deoxyribonucleic acid and affects the levels of serum and cervical mucus antibodies against human papillomavirus antigens. STUDY DESIGN: Analysis of paired cervical brush and serum samples taken from 23 women with cervical intraepithelial neoplasia before and 16 to 27 months after conization was performed for presence of human papillomavirus deoxyribonucleic acid by polymerase chain reaction and for human papillomavirus antibodies by enzyme-linked immunosorbent assay. RESULTS: Four women had recurrent cervical intraepithelial neoplasia, whereas 19 women were disease free. Eighteen of 23 women were positive for human papillomavirus deoxyribonucleic acid before treatment. At follow-up only the 4 women with recurrent cervical intraepithelial neoplasia were positive. Serum immunoglobulin G levels and A levels and immunoglobulin A levels in cervical mucus against most of the tested human papillomavirus antigens had declined at follow-up. CONCLUSIONS: Human papillomavirus deoxyribonucleic acid was regularly eliminated and human papillomavirus antibody levels, especially local immunoglobulin A, declined after efficient treatment, suggesting that conization may be effective for treating the underlying human papillomavirus infection. (AM J OBSTET GYNECOL 1996;174:937-42.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Schiffman MH
        • Bauer HM
        • Hoover RN
        • et al.
        Epidemiological evidence that human papillomavirus infection causes most cervical intraepithelial neoplasia.
        J Natl Cancer Inst. 1993; 85: 958-963
        • zur Hausen H.
        Viruses in human cancers.
        Science. 1991; 254: 1167-1173
        • Lorincz AT
        • Reid R
        • Jenson AB
        • Greenberg MD
        • Lancaster WD
        • Kurman RJ.
        Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.
        Obstet Gynecol. 1992; 79: 328-337
        • Koutsky L
        • Holmes KK
        • Critchlow CW
        • et al.
        A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.
        N Engl J Med. 1992; 327: 1272-1278
        • Syrjänen K
        Factors associated with the clinical behaviour of cervical human papillomavirus infections during a long-term prospective follow-up.
        Br J Obstet Gynaecol. 1988; 95: 1096-1102
        • Campion M
        • McCance DJ
        • Cuzick J
        • Singer A.
        Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study.
        Lancet. 1986; 2: 237-240
        • Brodman M
        • Dottino P
        • Friedman F
        • Heller D
        • Bleiweiss I
        • Sperling R.
        Human papillomavirus-associated lesions of the vagina and cervix: treatment with a laser and topical 5-fluorouracil.
        J Reprod Med. 1992; 37: 453-456
        • Ruge S
        • Felding C
        • Skouby SO
        • Lundvall F
        • Hörding U
        • Norrild B
        CO2-laser vaporization in the treatment of cervical human papillomavirus infection in women with abnormal Papanicolau smears.
        Gynecol Obstet Invest. 1992; 33: 172-176
        • Bistoletti P
        • Zellbi A
        • Moreno-Lopez J
        • Hjerpe A.
        Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN). III.
        Cancer. 1988; 62: 2056-2059
        • Nuovo G
        • Moritz J
        • Kowalik A
        • Chalas E
        • Kaplan B
        • Mann W.
        Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization.
        Gynecol Oncol. 1992; 46: 304-308
        • Nuovo GJ.
        Human papillomaviruses in recurrent CIN.
        Contemp OB/Gyn. 1995; 40: 9-19
        • Nuovo GJ.
        • Pedemonte BA.
        Human papillomavirus types and recurrent genital squamous intraepithelial lesions.
        JAMA. 1990; 263: 1223-1227
        • Schiffman MH.
        Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.
        J Natl Cancer Inst. 1992; 84: 394-398
        • Meijer CJLM
        • van den Brule AJC
        • Snijders PJF
        • Helmerhorst T
        • Kenemans P
        • Walboomers JMM.
        Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening.
        in: The epidemiology of human papillomavirus. IARC, Lyon1992: 271-281
        • Bosch FX
        • Munoz N
        • DeSanjose S
        • et al.
        Risk factors for cervical cancer in Colombia and Spain.
        Int J Cancer. 1992; 52: 750-758
        • Dillner J.
        Antibody responses to defined HPV epitopes in cervical neoplasia.
        Papillomavirus Report. 1994; 5: 35-41
        • Dillner J
        • Lenner P
        • Lehtinen M
        • et al.
        A population-based seroepidemiological study of cervical cancer.
        Cancer Res. 1994; 54: 134-141
        • Kirnbauer R
        • Hubbert NL
        • Wheeler CM
        • Becker TM
        • Lowy DR
        • Schiller JT.
        A virus-like particle ELISA detect serum antibodies in a majority of women infected with human papillomavirus type 16.
        J Natl Cancer Inst. 1994; 86: 494-498
        • Walboomers JMM
        • Melkert PWJ
        • Van den Brule AJC
        • Snijders PJF
        • Meijer CJLM
        The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix.
        in: Diagnostic molecular pathology: a practical approach. 2. Oxford University Press, Oxford1992: 153-172
        • Van den Brule AJC
        • Meijer CJLM
        • Bakels V
        • Kenemans P
        • Walboomers JMM.
        Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction.
        J Clin Microbiol. 1990; 28: 2739-2743
        • Heino P
        • Eklund C
        • Shahnazarian-Fredriksson V
        • Goldman S
        • Schiller JT
        • Dillner J.
        Serum IgG antibodies against human papillomavirus type 16 capsids associated with anal epidermoid carcinoma.
        J Natl Cancer Inst. 1995; 87: 437-440
        • Dillner L
        • Fredriksson A
        • Persson E
        • Forslund O
        • Hansson BG
        • Dillner J.
        Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.
        J Clin Microbiol. 1993; 31: 192-197
        • van Doornum GJJ
        • Prins M
        • Pronk L
        • Coutinho RA
        • Dillner J.
        Antibody levels against defined epitopes of human papillomavirus type 16 in relation to genital and anorectal presence of HPV DNA: a prospective study.
        Clin Diagn Lab Immunol. 1994; 1: 633-639
        • Sixbey JW
        • Lemon SM
        • Pagano JS.
        A second site for Epstein-Barr virus shedding: the uterine cervix.
        Lancet. 1986; 2: 1122-1124
        • Ferenczy A
        • Mitao M
        • Nagai N
        • Silverstein SJ
        • Crum CP.
        Latent papillomavirus and recurring genital warts.
        N Engl J Med. 1985; 313: 784-788
        • Sherman ME
        • Schiffman MH
        • Lorincz AT
        • et al.
        Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.
        Am J Clin Pathol. 1994; 102: 182-187